ArticleJournal of gynecologic oncology2025
Response to Corcept's retraction request on manuscript of "Relacorilant plus nab-paclitaxel for recurrent, platinum-resistant ovarian cancer: a cost-effectiveness study".
Qiaoping XuPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.